Searched for
PFIZER DRUG SALES
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...- US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Glenmark Pharma inks settlement pact with Pfizer for cancer drugThe Mumbai-based drug maker and its US-based unit have inked a settlement pact with drug major Pfizer Inc for Axitinib Tablets (1 mg and 5 ...
- Pfizer's COVID product sales to top $50 billion this year, investors want moreAlthough Pfizer raised its forecast for the vaccine, developed with Germany's BioNTech SE, by $1 billion to $32 billion, the drugmaker caut...
- Delhi High Court stays Corex ban on Pfizer’s petitionThe order is estimated to impact pharmaceutical brands worth Rs 3,800 crore sold in the Indian market, according to market research experts.
- Pfizer completes sale of animal health division to subsidiaryDrug maker Pfizer Ltd today said the company's shareholders have approved the sale of its animal health division to its subsidiary, Pfizer ...
- Companies to gain as Big Pharma goes genericFaced with losses once its blockbusters start losing patents, Big Pharma is now devising strategies to counter the impact.
- Cipla in talks with global cos for research agreementMumbai-based drugmaker Cipla is in talks with global pharma majors for a drug research and supply agreement, said a top company executive o...
- Pfizer scans India for shopping optionsPfizer has approached several Indian drugmakers for possible alliances as part of moves to try and bolster revenues threatened by the expir...
- Pfizer charges Sun with another patent violationA legal battle between Pfizer and Sun Pharmaceutical has escalated.
- Pfizer profit dips 2 percent, sales fall much morePfizer Inc posted a 2 percent drop in first-quarter profit Tuesday, as cost-cutting by the world's largest drugmaker couldn't offset big dr...
- Ranbaxy shares rise on buzz of Pfizer 'counter-offer'The share price of Ranbaxy Laboratories rose to a 3-year high on Friday based on the rumour that the world’s largest drug maker, Pfizer, ma...
- Ranbaxy's US launch of Lipitor drug only in 2010With the US Supreme Court rejecting an appeal by Ranbaxy to launch a generic drug of Lipitor in the US before its patent expires in 2010, R...
- Ranbaxy in Lipitor patent suit with Pfizer in 17 countriesIndia’s largest drug-maker Ranbaxy has locked horns with the US-based world’s largest drug-maker Pfizer in 17 countries.
- Pfizer may cut jobs, rejig biz to tide over crisisPfizer will likely slash staff and accelerate merger and licencing deals as the pressure on it to improve its financial performance intensi...
- Pfizer Q3 profit doubles to $3.4bnPfizer on Thursday said third-quarter earnings doubled from the year-ago quarter when it took a big merger-related charge, helped by strong...
Load More
